We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1.87B
AUM Growth
-$26.3M
Cap. Flow
-$145M
Cap. Flow %
-7.74%
Top 10 Hldgs %
63.21%
Holding
45
New
1
Increased
13
Reduced
22
Closed
1

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$15.6M
2
PG icon
Procter & Gamble
PG
+$7.37M
3
LLY icon
Eli Lilly
LLY
+$5.28M
4
NVO
Novo Nordisk
NVO
+$3.98M
5
HON icon
Honeywell
HON
+$770K

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$27.6M
2
NKE icon
Nike
NKE
+$23.9M
3
ORCL icon
Oracle
ORCL
+$22.7M
4
WMT icon
Walmart Inc
WMT
+$21.7M
5
AAPL icon
Apple
AAPL
+$21M

Sector Composition

Rank Sector Weight
1 Technology 22.76%
2 Healthcare 17.61%
3 Communication Services 16.21%
4 Consumer Staples 13.8%
5 Industrials 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.65T
$158M 8.47%
318,079
-2,979
-0.9% -$1.29M
DIS icon
2
Walt Disney
DIS
$178B
$155M 8.32%
1,253,656
-104,412
-8% -$10.8M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.19T
$147M 7.84%
831,445
-4,855
-0.6% -$795K
UL icon
4
Unilever
UL
$133B
$132M 7.06%
1,917,418
-89,194
-4% -$6.26M
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.09T
$125M 6.72%
258,265
-20,276
-7% -$10.3M
NVO
6
Novo Nordisk
NVO
$203B
$104M 5.59%
1,512,677
+58,517
+4% +$3.98M
MDT icon
7
Medtronic
MDT
$116B
$103M 5.51%
1,181,002
-176
-0% -$14.9K
ORCL icon
8
Oracle
ORCL
$443B
$98.6M 5.28%
450,920
-140,807
-24% -$22.7M
JNJ icon
9
Johnson & Johnson
JNJ
$629B
$76.6M 4.1%
501,415
-3,004
-0.6% -$462K
RTX icon
10
RTX Corp
RTX
$300B
$61.1M 3.27%
418,167
-207,107
-33% -$27.6M
ASML icon
11
ASML
ASML
$700B
$60.1M 3.22%
75,008
+203
+0.3% +$146K
GD icon
12
General Dynamics
GD
$107B
$60.1M 3.22%
206,088
-8,777
-4% -$2.42M
SBUX icon
13
Starbucks
SBUX
$123B
$46.8M 2.5%
510,482
+1,996
+0.4% +$173K
ACN icon
14
Accenture
ACN
$109B
$44.7M 2.39%
149,552
-1,087
-0.7% -$331K
V icon
15
Visa
V
$671B
$43.2M 2.31%
121,642
-44,513
-27% -$15.5M
CHRW icon
16
C.H. Robinson
CHRW
$17.3B
$42.5M 2.28%
443,311
-11,116
-2% -$1.04M
HD icon
17
Home Depot
HD
$343B
$36.5M 1.96%
99,605
-1,727
-2% -$625K
DEO icon
18
Diageo
DEO
$51.9B
$34.4M 1.84%
341,086
-1,613
-0.5% -$175K
PG icon
19
Procter & Gamble
PG
$336B
$33.2M 1.78%
208,643
+45,130
+28% +$7.37M
LLY icon
20
Eli Lilly
LLY
$1.09T
$29M 1.55%
37,233
+6,797
+22% +$5.28M
AAPL icon
21
Apple
AAPL
$4.4T
$27.4M 1.47%
133,633
-103,809
-44% -$21M
BIL icon
22
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$22.9M 1.23%
249,882
-3,406
-1% -$312K
PEP icon
23
PepsiCo
PEP
$189B
$22.1M 1.18%
167,435
+1,905
+1% +$257K
NKE icon
24
Nike
NKE
$60.4B
$18.2M 0.97%
255,501
-398,812
-61% -$23.9M
CL icon
25
Colgate-Palmolive
CL
$73.9B
$17.8M 0.95%
195,696
+2,140
+1% +$195K
1
2

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return

Saratoga Research & Investment Management's Q2 2025 Portfolio in Review

As of Q2 2025, Saratoga Research & Investment Management held 45 positions worth $1.87B, down 1.4% from $1.89B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Saratoga Research & Investment Management withdrew a net $145M in Q2 2025, closing 1 position and reducing 22 holdings. Its most notable exit was Becton Dickinson, an estimated $220K position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Saratoga Research & Investment Management opened a new position in Zoetis worth $15.4M.

  • Saratoga Research & Investment Management's largest Q2 2025 buy was Zoetis: 98,597 shares worth $15.4M.
  • Saratoga Research & Investment Management added most to Procter & Gamble in Q2 2025, an estimated $7.37M increase.
  • Saratoga Research & Investment Management's biggest Q2 2025 reduction was RTX Corp, cutting an estimated $27.6M.
  • Saratoga Research & Investment Management fully exited Becton Dickinson in Q2 2025, selling an estimated $220K.
  • Saratoga Research & Investment Management's ten largest holdings make up 63% of its $1.87B portfolio in Q2 2025.
  • Saratoga Research & Investment Management opened 1 new position and closed 1 in Q2 2025.
  • Saratoga Research & Investment Management's portfolio value fell 1.4% quarter-over-quarter to $1.87B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2025, filed 20 Aug 2025.